Literature DB >> 9701976

[Subtotal thyroidectomy or total thyroidectomy in the treatment of benign thyroid disease. Our experience].

G Siragusa1, P Lanzara, G Di Pace.   

Abstract

During the period January 1989-December 1994, of 322 thyroid operations, 309 were benign. The pathologic changes in the excised thyroids were 18 benign adenoma, 291 goiter 9 of which with thyroiditis. 25 patients had undergone previous partial thyroidectomy. Total thyroidectomy was performed in 224 patients. There were no operative deaths. 77 (34.3%) patients developed postoperative hypocalcemia, 10 (2.7%) transient hypoparathyroidism, 4 (1.8%) permanent hypoparathyroidism, 3 (1.3%) transient recurrent laryngeal nerve palsies, 2 (0.9%) permanent nerve damages. In our experience total thyroidectomy is the gold standard for diffuse diseases of the thyroid, because, without more specific complication than subtotal thyroidectomy, it ensures: no recurrences, an easy control of postoperative hypothyroidism, the removal of microscopic malignant foci, the stopping of ophthalmopathy evolution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701976

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  3 in total

1.  Total versus bilateral subtotal thyroidectomy for benign multi-nodular goiter.

Authors:  Fatih Ciftci; Erdal Sakalli; Ibrahim Abdurrahman
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter.

Authors:  Serdar Tezelman; Ismail Borucu; Yasemin Senyurek Giles; Fatih Tunca; Tarik Terzioglu
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

3.  Standard-radical vs. function-preserving surgery of benign nodular goiter: a sonographic and biochemical 10-year follow-up study.

Authors:  N Lehwald; K Cupisti; H S Willenberg; M Schott; M Krausch; A Raffel; A Wolf; K Brinkmann; C F Eisenberger; W T Knoefel
Journal:  Langenbecks Arch Surg       Date:  2008-04-09       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.